Vjhemonc Podcast

MPN highlights at ASH 2023: novel agents & ongoing clinical trials in ET, PV and MF

Informações:

Synopsis

The treatment of the BCR-ABL1-negative myeloproliferative neoplasms (MPNs), including myelofibrosis (MF), polycythemia vera (PV) and essential thrombocythemia (ET), has transformed... The post MPN highlights at ASH 2023: novel agents & ongoing clinical trials in ET, PV and MF appeared first on VJHemOnc.